• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性中心性浆液性脉络膜视网膜病变光动力治疗后视网膜外层微观结构的变化

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy.

作者信息

Shimizu Kimiko, Hashimoto Yohei, Azuma Keiko, Nomura Yoko, Obata Ryo, Takahashi Hidenori, Yanagi Yasuo

机构信息

Department of Ophthalmology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo.

Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.

出版信息

Clin Ophthalmol. 2017 Aug 16;11:1505-1512. doi: 10.2147/OPTH.S139288. eCollection 2017.

DOI:10.2147/OPTH.S139288
PMID:28860700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5566507/
Abstract

PURPOSE

To evaluate the morphological changes in retinal microstructures following modified photodynamic therapy (PDT) for chronic central serous chorioretinopathy.

SUBJECTS AND METHODS

Retrospective study of 21 consecutive eyes (age, 59±8.0 years [mean ± SD]) of 21 patients with chronic central serous chorioretinopathy. Inner foveal thickness (the distance between the internal limiting membrane and external limiting membrane), photoreceptor outer segment (PROS) length at the point without serous retinal detachment and choroidal thickness were assessed with enhanced depth imaging optical coherence tomography before treatment and at 1, 3 and 6 months after modified PDT.

RESULTS

Six eyes had half-dose and 15 eyes had half-fluence PDT. PROS length within the irradiated area was significantly decreased by 3.9% at 1 month compared with that before modified PDT (43.5±5.72 and 40.5±7.53, =0.020 [paired -test]) and returned to baseline length at 3 and 6 months (43.0±5.42 and 43.5±4.33 μm [mean ± SD]; =0.53 and 1.00 [paired -test]). PROS length of the nonirradiated area at 1, 3 and 6 months after modified PDT did not significantly differ from that before PDT (41.8±6.35, 41.4±5.33, 41.9±4.67 and 42.3±4.26 μm [mean ± SD]; =0.66, 0.90 and 0.60, respectively [paired -test]). There was no significant change in inner foveal thickness during the observation period. At all time points, choroidal thickness was significantly thinner than it was before PDT (<0.001, paired -test).

CONCLUSION

Modified PDT may cause mild temporary microstructural changes.

摘要

目的

评估改良光动力疗法(PDT)治疗慢性中心性浆液性脉络膜视网膜病变后视网膜微观结构的形态学变化。

受试者与方法

对21例慢性中心性浆液性脉络膜视网膜病变患者的21只连续眼(年龄,59±8.0岁[均值±标准差])进行回顾性研究。在治疗前以及改良PDT治疗后1、3和6个月,使用增强深度成像光学相干断层扫描评估中心凹内层厚度(内界膜与外界膜之间的距离)、无浆液性视网膜脱离处的光感受器外段(PROS)长度以及脉络膜厚度。

结果

6只眼接受了半剂量PDT,15只眼接受了半光通量PDT。与改良PDT治疗前相比,照射区域内的PROS长度在1个月时显著降低了3.9%(43.5±5.72和40.5±7.53,P = 0.020[配对t检验]),并在3个月和6个月时恢复至基线长度(43.0±5.42和43.5±4.33μm[均值±标准差];P = 0.53和1.00[配对t检验])。改良PDT治疗后1、3和6个月时,未照射区域的PROS长度与PDT治疗前相比无显著差异(41.8±6.35、41.4±5.33、41.9±4.67和42.3±4.26μm[均值±标准差];P分别为0.66、0.90和0.60[配对t检验])。观察期内中心凹内层厚度无显著变化。在所有时间点,脉络膜厚度均显著薄于PDT治疗前(P<0.001;配对t检验)。

结论

改良PDT可能会引起轻度的暂时性微观结构变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/4aed14a00658/opth-11-1505Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/5339d8cb8f19/opth-11-1505Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/f4e54448f16a/opth-11-1505Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/3c6884677e61/opth-11-1505Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/f6bf44ac3ed0/opth-11-1505Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/4aed14a00658/opth-11-1505Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/5339d8cb8f19/opth-11-1505Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/f4e54448f16a/opth-11-1505Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/3c6884677e61/opth-11-1505Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/f6bf44ac3ed0/opth-11-1505Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ac/5566507/4aed14a00658/opth-11-1505Fig5.jpg

相似文献

1
Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变光动力治疗后视网膜外层微观结构的变化
Clin Ophthalmol. 2017 Aug 16;11:1505-1512. doi: 10.2147/OPTH.S139288. eCollection 2017.
2
Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.频域光学相干断层扫描在慢性中心性浆液性脉络膜视网膜病变半剂量维替泊芬光动力治疗前后形态改变的检测。
Retina. 2011 Oct;31(9):1912-20. doi: 10.1097/IAE.0b013e3182252aa8.
3
Comparison of Retinochoroidal Vascular and Structural Changes after Half-Dose Photodynamic Therapy versus Half-Fluence Photodynamic Therapy Based on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.基于 OCTA 对慢性中心性浆液性脉络膜视网膜病变眼行半剂量与半光强 PDT 后脉络膜视网膜血管及结构变化的比较。
Ophthalmologica. 2022;245(4):323-334. doi: 10.1159/000523704. Epub 2022 Mar 4.
4
Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变:视力预后的易感因素
Semin Ophthalmol. 2018;33(5):690-699. doi: 10.1080/08820538.2017.1416414. Epub 2017 Dec 18.
5
Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者半剂量光动力疗法后的微观结构变化。
Photodiagnosis Photodyn Ther. 2021 Sep;35:102347. doi: 10.1016/j.pdpdt.2021.102347. Epub 2021 May 24.
6
[Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy].[光动力疗法治疗慢性或复发性中心性浆液性脉络膜视网膜病变]
Zhonghua Yan Ke Za Zhi. 2012 Feb;48(2):106-13.
7
Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后圆锥外节尖端线的完整性与视网膜敏感性的相关性。
Am J Ophthalmol. 2012 Sep;154(3):579-85. doi: 10.1016/j.ajo.2012.03.043. Epub 2012 Jul 20.
8
ELONGATED PHOTORECEPTOR OUTER SEGMENT LENGTH AND PROGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.慢性中心性浆液性脉络膜视网膜病变的延长的光感受器外段长度与预后
Retina. 2020 Apr;40(4):750-757. doi: 10.1097/IAE.0000000000002445.
9
Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.中浆患者接受半剂量光动力疗法后的长期外层视网膜改变。
Photodiagnosis Photodyn Ther. 2021 Jun;34:102235. doi: 10.1016/j.pdpdt.2021.102235. Epub 2021 Feb 22.
10
Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.光学相干断层扫描血管造影评估半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后早期脉络膜毛细血管的变化:初步结果。
Photodiagnosis Photodyn Ther. 2018 Mar;21:375-378. doi: 10.1016/j.pdpdt.2018.01.015. Epub 2018 Feb 2.

引用本文的文献

1
Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变光动力治疗后的视网膜解剖学变化
J Ophthalmol. 2018 Feb 6;2018:4081874. doi: 10.1155/2018/4081874. eCollection 2018.

本文引用的文献

1
Evaluation of nailfold videocapillaroscopy in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的甲襞视频毛细血管镜检查评估
Graefes Arch Clin Exp Ophthalmol. 2016 Oct;254(10):1889-1896. doi: 10.1007/s00417-016-3322-1. Epub 2016 Mar 19.
2
CORRELATION OF OPTICAL INTENSITY ON OPTICAL COHERENCE TOMOGRAPHY AND VISUAL OUTCOME IN CENTRAL RETINAL ARTERY OCCLUSION.光学相干断层扫描的光强度与视网膜中央动脉阻塞视觉预后的相关性
Retina. 2016 Oct;36(10):1964-70. doi: 10.1097/IAE.0000000000001017.
3
PHOTORECEPTOR OUTER SEGMENT LENGTH AND OUTER FOVEAL THICKNESS AS FACTORS ASSOCIATED WITH VISUAL OUTCOME AFTER VITRECTOMY FOR VITREOMACULAR TRACTION SYNDROME.
光感受器外段长度和中央凹外厚度与玻璃体黄斑牵引综合征玻璃体切除术后视觉预后的相关性
Retina. 2016 Sep;36(9):1707-12. doi: 10.1097/IAE.0000000000000985.
4
Comparison of photoreceptor outer segment length in diabetic and idiopathic epiretinal membranes.糖尿病性和特发性视网膜前膜中光感受器外段长度的比较。
Eye (Lond). 2015 Nov;29(11):1446-52. doi: 10.1038/eye.2015.133. Epub 2015 Jul 17.
5
One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半剂量维替泊芬光动力疗法治疗一年的结果。
Ophthalmology. 2015 Mar;122(3):555-61. doi: 10.1016/j.ophtha.2014.09.034. Epub 2014 Nov 18.
6
Long-term follow-up of photoreceptor loss and recovery after half-fluence photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半量光动力疗法后光感受器丧失与恢复的长期随访
Retin Cases Brief Rep. 2015 Spring;9(2):109-13. doi: 10.1097/ICB.0000000000000105.
7
Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy.光动力疗法治疗息肉样脉络膜血管病变后激光照射区外脉络膜厚度。
Jpn J Ophthalmol. 2013 May;57(3):294-300. doi: 10.1007/s10384-013-0230-3. Epub 2013 Feb 14.
8
Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy.半剂量光动力疗法治疗中心性浆液性脉络膜视网膜病变中的光感受器破坏
Clin Ophthalmol. 2013;7:87-92. doi: 10.2147/OPTH.S39584. Epub 2013 Jan 10.
9
Photoreceptor outer segment length: a prognostic factor for idiopathic epiretinal membrane surgery.光感受器外节长度:特发性眼内膜手术的预后因素。
Ophthalmology. 2013 Apr;120(4):788-94. doi: 10.1016/j.ophtha.2012.09.044. Epub 2013 Jan 3.
10
Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.中心性浆液性脉络膜视网膜病变自发缓解和低强度光动力疗法后 脉络膜厚度的变化。
Eye (Lond). 2013 Mar;27(3):387-91. doi: 10.1038/eye.2012.273. Epub 2013 Jan 4.